Azienda Socio Sanitaria Territoriale Papa Giovanni Xxiii

The clinical research activity is centered on Hereditary Spastic Paraplegia Type 50 (SPG50), a rare neurogenetic disorder affecting motor function and spasticity. The sponsor’s research interest is focused on disease areas involving inherited neurological impairment and targeted molecular correction.

• Hereditary Spastic Paraplegia Type 50
• Motor pathway dysfunction
• Rare inherited neurological disease

The funded study reflects involvement in rare disease care within a hospital-based setting in Bergamo, Italy.